Alyssa B Dufour1,2, Michele L Shaffer3,4, Erika M C D'Agata5, Daniel Habtemariam1, Susan L Mitchell1,2. 1. Hebrew SeniorLife, Institute for Aging Research, Boston, Massachusetts. 2. Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. 3. Department of Pediatrics, University of Washington, Seattle, Washington. 4. Children's Core for Biomedical Statistics, Seattle Children's Research Institute, Seattle, Washington. 5. Division of Infectious Diseases, Rhode Island Hospital, Brown University, Providence, Rhode Island.
Abstract
OBJECTIVES: To determine whether antimicrobial treatment for suspected urinary tract infections (UTIs) improves survival in nursing home residents with advanced dementia. DESIGN: Prospective cohort study. SETTING: Thirty-five nursing homes in Boston, Massachusetts. PARTICIPANTS: Nursing home residents who experienced at least one suspected UTI over a 12-month period (N = 110); mean participant age 86.4 ± 6.2, 84% female. MEASUREMENTS: Analyses were at the level of the UTI episode. Antimicrobial treatment for each suspected UTI was categorized as none, oral, intramuscular, or intravenous or hospitalization. Survival was calculated from the date of suspected UTI episode until death or last known follow-up date. Covariates included resident and episode characteristics. Cox proportional hazards regression was used to examine the association between treatment group and risk of death after adjusting for covariates. RESULTS: Residents experienced 196 suspected UTIs over the follow-up period; 33% (n = 36) died during follow-up. There was no antimicrobial use for 25.0% of the 196 suspected UTIs, oral antimicrobial use in 59.7%; intramuscular antimicrobial use in 9.2%, and intravenous antimicrobial use or hospital transfer in 6.1%. After multivariable adjustment, antimicrobial treatment was not significantly associated with mortality (oral, adjusted hazard ratio for death (AHR) = 1.09, 95% confidence interval (CI) = 0.43-2.75; intramuscular, AHR = 0.66, 95% CI = 0.08-5.66; intravenous or hospitalization, AHR = 1.83, 95% CI = 0.44-7.60). CONCLUSION: Although the majority of suspected UTIs that nursing home residents with advanced dementia experienced were treated with antimicrobials, treatment was not associated with survival.
OBJECTIVES: To determine whether antimicrobial treatment for suspected urinary tract infections (UTIs) improves survival in nursing home residents with advanced dementia. DESIGN: Prospective cohort study. SETTING: Thirty-five nursing homes in Boston, Massachusetts. PARTICIPANTS: Nursing home residents who experienced at least one suspected UTI over a 12-month period (N = 110); mean participant age 86.4 ± 6.2, 84% female. MEASUREMENTS: Analyses were at the level of the UTI episode. Antimicrobial treatment for each suspected UTI was categorized as none, oral, intramuscular, or intravenous or hospitalization. Survival was calculated from the date of suspected UTI episode until death or last known follow-up date. Covariates included resident and episode characteristics. Cox proportional hazards regression was used to examine the association between treatment group and risk of death after adjusting for covariates. RESULTS: Residents experienced 196 suspected UTIs over the follow-up period; 33% (n = 36) died during follow-up. There was no antimicrobial use for 25.0% of the 196 suspected UTIs, oral antimicrobial use in 59.7%; intramuscular antimicrobial use in 9.2%, and intravenous antimicrobial use or hospital transfer in 6.1%. After multivariable adjustment, antimicrobial treatment was not significantly associated with mortality (oral, adjusted hazard ratio for death (AHR) = 1.09, 95% confidence interval (CI) = 0.43-2.75; intramuscular, AHR = 0.66, 95% CI = 0.08-5.66; intravenous or hospitalization, AHR = 1.83, 95% CI = 0.44-7.60). CONCLUSION: Although the majority of suspected UTIs that nursing home residents with advanced dementia experienced were treated with antimicrobials, treatment was not associated with survival.
Authors: M Loeb; D W Bentley; S Bradley; K Crossley; R Garibaldi; N Gantz; A McGeer; R R Muder; J Mylotte; L E Nicolle; B Nurse; S Paton; A E Simor; P Smith; L Strausbaugh Journal: Infect Control Hosp Epidemiol Date: 2001-02 Impact factor: 3.254
Authors: Susan L Mitchell; Betty S Black; Mary Ersek; Laura C Hanson; Susan C Miller; Greg A Sachs; Joan M Teno; R Sean Morrison Journal: Ann Intern Med Date: 2012-01-03 Impact factor: 25.391
Authors: Susan L Mitchell; Michele L Shaffer; Mark B Loeb; Jane L Givens; Daniel Habtemariam; Dan K Kiely; Erika D'Agata Journal: JAMA Intern Med Date: 2014-10 Impact factor: 21.873
Authors: Susan L Mitchell; Joan M Teno; Dan K Kiely; Michele L Shaffer; Richard N Jones; Holly G Prigerson; Ladislav Volicer; Jane L Givens; Mary Beth Hamel Journal: N Engl J Med Date: 2009-10-15 Impact factor: 91.245
Authors: Aurora Pop-Vicas; Susan L Mitchell; Ruth Kandel; Robert Schreiber; Erika M C D'Agata Journal: J Am Geriatr Soc Date: 2008-06-28 Impact factor: 5.562
Authors: Halima Amjad; Donald Carmichael; Andrea M Austin; Chiang-Hua Chang; Julie P W Bynum Journal: JAMA Intern Med Date: 2016-09-01 Impact factor: 21.873
Authors: Mairead M Bartley; Laura Suarez; Reem M A Shafi; Joshua M Baruth; Amanda J M Benarroch; Maria I Lapid Journal: Curr Psychiatry Rep Date: 2018-06-23 Impact factor: 5.285
Authors: Andrea J Loizeau; Erika M C D'Agata; Michele L Shaffer; Laura C Hanson; Ruth A Anderson; Timothy Tsai; Daniel A Habtemariam; Elaine H Bergman; Ruth P Carroll; Simon M Cohen; Erin M E Scott; Erin Stevens; Jeremy D Whyman; Elizabeth H Bennert; Susan L Mitchell Journal: Trials Date: 2019-10-15 Impact factor: 2.279
Authors: David A Nace; Subashan K Perera; Joseph T Hanlon; Stacey Saracco; Gulsum Anderson; Steven J Schweon; Michele Klein-Fedyshin; Charles B Wessel; Mary Mulligan; Paul J Drinka; Christopher J Crnich Journal: J Am Med Dir Assoc Date: 2018-07-20 Impact factor: 4.669